Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates

PURPOSE: Within the last decade, SurePath and ThinPrep [both liquid-based cytology (LBC) tests] have replaced conventional cytology (CC) as primary test method in cervical cancer screening programs of multiple countries. The aim of our study was to examine the effect in the Dutch screening program....

Descripción completa

Detalles Bibliográficos
Autores principales: Rozemeijer, Kirsten, Penning, Corine, Siebers, Albert G., Naber, Steffie K., Matthijsse, Suzette M., van Ballegooijen, Marjolein, van Kemenade, Folkert J., de Kok, Inge M. C. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703623/
https://www.ncbi.nlm.nih.gov/pubmed/26458884
http://dx.doi.org/10.1007/s10552-015-0678-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703623/
https://www.ncbi.nlm.nih.gov/pubmed/26458884
http://dx.doi.org/10.1007/s10552-015-0678-1

Ejemplares similares